PCSK9 in Brain Health and Disease: Liver-Vascular-Brain Interactions in Aging and Disease
aging and disease · 2026
DOI: 10.14336/ad.2026.0209 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift aging and disease, 2026. Verfasst von Mengqi Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, San Francisco & San Francisco Veterans Affairs Medical Center, San Francisco, CA 94158, USA.
Abstract (Originalsprache)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of peripheral cholesterol metabolism. Inhibitors of hepatic PCSK9 potently reduce low-density lipoprotein cholesterol (LDL-C) and have become a staple of lipid-lowering therapeutic regimens for patients with atherosclerotic cardiovascular disease. Although the role of PCSK9 in the central nervous system (CNS) is less well-defined, accumulating evidence suggests that it modulates CNS cholesterol homeostasis and responses to injury, neuroinflammation, and amyloid-β and tau protein deposition. Thus, peripheral and central PCSK9 molecular actions have important pathophysiological consequences for aging, cerebrovascular disease, and neurodegenerative disease. In this review, we summarize PCSK9 functions in the context of the liver-vascular-brain axis and examine mechanistic and therapeutic links in PCSK9 biology and neurological diseases. By integrating insights from preclinical and clinical research, we highlight the current state of knowledge regarding the potential relevance of PCSK9-inhibiting therapies in brain health and disease. Given the remarkable lipid-lowering effects of PCSK9 inhibitors, advancing our understanding of the multi-organ interactions influenced by PCSK9 may inform future therapeutic strategies, although clinical evidence supporting neurological benefit currently remains limited.
Autor:innen und Institutionen
- Department of Neurology, University of California, San Francisco & San Francisco Veterans Affairs Medical Center, San Francisco, CA 94158, USA.
Zitieren
APA
Zhang, M., & Singhal, N. S. (2026). PCSK9 in Brain Health and Disease: Liver-Vascular-Brain Interactions in Aging and Disease. aging and disease. https://doi.org/10.14336/ad.2026.0209
Vancouver
Zhang M, Singhal NS. PCSK9 in Brain Health and Disease: Liver-Vascular-Brain Interactions in Aging and Disease. aging and disease. 2026. doi:10.14336/ad.2026.0209
BibTeX
@article{Zhang2026,
author = {Zhang, Mengqi and Singhal, Neel S},
title = {PCSK9 in Brain Health and Disease: Liver-Vascular-Brain Interactions in Aging and Disease},
journal = {aging and disease},
year = {2026},
doi = {10.14336/ad.2026.0209}
}
EUVIMED